We are live on ! Find out more
TI

Telemetry Investments Portfolio holdings

AUM $63.3M
1-Year Est. Return 0.06%
This Fund
S&P 500
This Quarter Est. Return
+2.18%
1 Year Est. Return
+0.06%
3 Year Est. Return
+77.42%
5 Year Est. Return
+156.79%
10 Year Est. Return
AUM
$74.2M
AUM Growth
+$1.49M
Cap. Flow
+$4.88M
Cap. Flow %
6.58%
Top 10 Hldgs %
25.39%
Holding
206
New
67
Increased
36
Reduced
36
Closed
46
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GPX
26
DELISTED
GP Strategies Corp.
GPX
$866K 1.17%
+41,833
New +$830K
SDST
27
Stardust Power Inc
SDST
$7.4M
$865K 1.17%
8,920
-1,294
-13% -$126K
HPLTU
28
DELISTED
Home Plate Acquisition Corporation Unit
HPLTU
$826K 1.11%
+83,738
New +$826K
FCX icon
29
CALL
Freeport-McMoran
FCX
$91.5B
$813K 1.1%
25,000
AFMD
30
DELISTED
Affimed
AFMD
$810K 1.09%
13,102
+4,191
+47% +$276K
CAI
31
DELISTED
CAI International, Inc.
CAI
$752K 1.01%
+13,443
New +$751K
SCYX icon
32
SCYNEXIS
SCYX
$50.3M
$746K 1.01%
17,595
+875
+5% +$45.8K
WBT
33
DELISTED
Welbilt, Inc.
WBT
$741K 1%
31,900
+16,300
+104% +$383K
BABA icon
34
Alibaba
BABA
$305B
$740K 1%
5,000
+1,900
+61% +$346K
NUAN
35
DELISTED
Nuance Communications, Inc.
NUAN
$740K 1%
13,448
+948
+8% +$52.1K
MIR icon
36
Mirion Technologies
MIR
$3.9B
$726K 0.98%
71,000
+1,000
+1% +$10.1K
BAC icon
37
Bank of America
BAC
$438B
$722K 0.97%
17,000
GANX icon
38
Gain Therapeutics
GANX
$74.6M
$716K 0.96%
96,232
+65,939
+218% +$551K
FZT
39
DELISTED
FAST Acquisition Corp. II
FZT
$702K 0.95%
72,360
-3,979
-5% -$38.6K
PSTH
40
DELISTED
Pershing Square Tontine Holdings, Ltd.
PSTH
$670K 0.9%
34,000
-3,086
-8% -$62.6K
AMYT
41
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
$615K 0.83%
50,908
+13,756
+37% +$155K
QADB
42
DELISTED
QAD Inc. Class B
QADB
$601K 0.81%
+6,892
New +$596K
ACRS icon
43
Aclaris Therapeutics
ACRS
$772M
$567K 0.76%
31,500
-2,518
-7% -$40.4K
AGGR
44
DELISTED
Agile Growth Corp
AGGR
$562K 0.76%
57,841
+3,508
+6% +$33.9K
CFRX
45
DELISTED
ContraFect Corporation
CFRX
$544K 0.73%
1,680
+39
+2% +$12.1K
NKGN
46
DELISTED
NKGen Biotech, Inc. Common Stock
NKGN
$524K 0.71%
+54,061
New +$527K
TCON
47
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$505K 0.68%
6,525
+4,525
+226% +$383K
FRTX
48
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$504K 0.68%
15,541
+1,986
+15% +$64.4K
ANAC
49
DELISTED
Arctos NorthStar Acquisition Corp.
ANAC
$488K 0.66%
50,000
-43,961
-47% -$427K
PARA
50
DELISTED
Paramount Global Class B
PARA
$482K 0.65%
+12,200
New +$497K

Similar funds

Telemetry Investments's Q3 2021 Portfolio in Review

As of Q3 2021, Telemetry Investments held 206 positions worth $74.2M, up 2% from $72.7M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Telemetry Investments deployed $4.88M of net new capital in Q3 2021, opening 67 new positions and adding to 36 existing holdings. Its largest new stake was Angel Pond Holdings Corporation: 300,681 shares worth $2.9M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 18% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Biotech Acquisition Company Class A Ordinary Shares, an estimated $1.01M trimmed.

  • Telemetry Investments's largest Q3 2021 buy was Angel Pond Holdings Corporation: 300,681 shares worth $2.9M.
  • Telemetry Investments added most to VEREIT, Inc. in Q3 2021, an estimated $777K increase.
  • Telemetry Investments's biggest Q3 2021 reduction was Biotech Acquisition Company Class A Ordinary Shares, cutting an estimated $1.01M.
  • Telemetry Investments fully exited Angel Pond Holdings Corporation Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant in Q3 2021, selling an estimated $3.03M.
  • Telemetry Investments's ten largest holdings make up 25% of its $74.2M portfolio in Q3 2021.
  • Telemetry Investments opened 67 new positions and closed 46 in Q3 2021.
  • Telemetry Investments's portfolio value rose 2% quarter-over-quarter to $74.2M.

Based on Telemetry Investments's 13F filing for Q3 2021, filed 15 Nov 2021.